Mayo Clinic develops and validates new antibody test to diagnose multiple sclerosis - Insights
Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research...
New Tests Launched in February - Insights
In February 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
As Winter Storm Blair moves through the Midwest and East Coast, Mayo Clinic Laboratories will monitor and track the situation with our logistics partners to minimize challenges. If any routes are modified or canceled, clients in the...
New Tests Launched in November - Insights
In November 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Five Steps to Improve Transfusion Medicine - Insights
Blood transfusion is the most common procedure performed in hospitals in the U.S. Yet published evidence shows significant gaps in clinicians' knowledge of this critical aspect of patient care, including possible adverse reactions that can...
Hereditary testing by specialty - Insights
Mayo Clinic Laboratories is a one-stop laboratory for hereditary testing, featuring a robust menu of molecular, cytogenic, biochemical, and functional assays that support diagnosis and care.
New Tests Launched in July - Insights
In July 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Week in Review: April 21 - Insights
Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.
Collaboration identifies previously unknown blood clotting condition - Insights
A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.
Live and virtual meetings featuring general sessions, breakouts, panel discussions, and case studies, led by laboratory leaders and health care industry experts.